Kang He
14PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Jan 09, 2026
Should the China-CLIF framework influence model for end-stage liver disease-based transplant priority in acute-on-chronic liver failure?Kang He, Chengpeng Zhong, Qiang Xia
|Dec 10, 2025
Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.Kang He, Xue-Jing Zhu, Yao-Ping Shi
|Nov 05, 2025
Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.Kang He, Xue-Jing Zhu, Yao-Ping Shi
|Nov 05, 2025
Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study.Jun Fang, Siyi Zhong, Tielong Wang
|Jul 07, 2025
Rescued with T and B lymphocytes depletion therapy for immune checkpoint inhibitor-associated transplant rejection.Siqi Qiu, Zhipeng Zong, Kang He
|Mar 14, 2025
Atezolizumab and Bevacizumab prior to liver transplantation in hepatic angiosarcoma mimicking hepatocellular carcinoma.Siqi Qiu, Zhipeng Zong, Kang He
Pageof 3
Frequent Collaborators
4 joint publications
Qiang Xia
2 joint publications
He-Xin Yan
2 joint publications
Wei-Feng Yu
2 joint publications
Amar Deep Sharma
2 joint publications
Bo Zhai
2 joint publications
Fang-Rong Yan
2 joint publications
Pei-Ying Li
1 joint publications
Yangbo Yue
1 joint publications
De-Fu Kong
1 joint publications
Jie Zhao
